|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0566 SEK | -0.35% |
|
+2.54% | -64.71% |
| 06-13 | Chordate Medical Holding AB Enters New Partnership Agreement with Neurolite AG | CI |
| 05-24 | Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chordate Medical Holding AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 0.63863 million compared to SEK 0.120421 million a year ago. Revenue was SEK 0.643563 million compared to SEK 0.123568 million a year ago.
Net loss was SEK 6.02 million compared to SEK 7.11 million a year ago. Basic loss per share from continuing operations was SEK 0.02 compared to SEK 0.03 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -64.71% | 2.63M | |
| +7.77% | 218B | |
| +10.16% | 189B | |
| +26.21% | 151B | |
| +32.78% | 113B | |
| +1.56% | 64.02B | |
| +14.48% | 52.6B | |
| +2.92% | 49.85B | |
| -6.60% | 37.89B | |
| -1.07% | 34.92B |
CHORDATE MEDICAL HOLDING AB 